Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Cloudastructure, Inc., a cloud-native AI surveillance and remote guarding company, announced its management team's upcoming virtual presentation at the Webull Emerging & Innovative Companies Webinar on October 14, 2026. The company highlights its advanced cloud-based security platform and its innovative AI/ML analytics for enterprise security solut…
NETCLASS TECHNOLOGY INC (Nasdaq: NTCL) announced its strategic expansion into interactive AI companion smart hardware with the launch of LinkeeBot, an AI smart pet designed for college students and young professionals in key Asian markets. The company formed a joint venture, Linkee AI Company Limited, holding a 40% stake to commercialize this innov…
State Street (STT) looks attractively positioned as a high-quality, institutional-services bank with a clean balance sheet, recurring revenue streams, and a modest valuation. With consensus expecting a strong Q3 report and the stock trading well below key moving averages, we prefer a tactical long into a mid-term horizon to capture potential earnin…
Broadcom's share-price pullback has more to do with confused headlines than fundamentals. The company sits at the center of AI infrastructure - networking silicon, high-speed NICs, and software - and should be a primary beneficiary as cloud and model-builders scale capacity. Given strong free cash flow, a manageable balance sheet, recent product an…
OFA Group completed the acquisition and title registration of the Tokawa property in Choshi, Japan, adding a company-owned coastal real estate asset to its portfolio. The company is exploring the possibility of developing a premium, private-pay senior living and wellness-oriented community at this site, furthering its long-term presence and investm…
Arcutis Biotherapeutics shared positive clinical trial and real-world research data on its topical therapy ZORYVE (roflumilast) at recent dermatology conferences, including promising results in infants with atopic dermatitis, psoriasis, and seborrheic dermatitis. The data support expanded use in vulnerable populations and highlight potential advant…
Fiverr International Ltd. will release its financial results for the third quarter ended September 30, 2026, before the market opens on October 29, 2026. A conference call and webcast will be held the same day to discuss business and financial results. The company continues to focus on transforming the future of work via its platform connecting fre…
Eupraxia Pharmaceuticals announced that three abstracts from their ongoing Phase 1b/2 RESOLVE trial of EP-104GI, a local drug delivery treatment for eosinophilic esophagitis (EoE), will be presented at the American College of Gastroenterology (ACG) and United European Gastroenterology (UEG) 2026 conferences. The data highlight improvements in dysph…
Rezolve Ai has introduced RezolvePay, a payment and commerce infrastructure that allows AI-driven consumer shopping agents to interact seamlessly with merchant systems and complete purchases both online and in physical stores. This new platform positions Rezolve Ai to capitalize on the emerging agentic commerce market, potentially addressing $3 to …
Milestone Pharmaceuticals has enrolled its first European participant in the ReVeRA-301 Phase 3 clinical trial evaluating etripamil nasal spray for treating atrial fibrillation with rapid ventricular rate (AFib-RVR). The trial aims to enroll approximately 150 patients across multiple sites including the Dutch Cardiovascular Investigator Network to …
Nuvectis Pharma, a clinical-stage biopharmaceutical company focused on complement-related conditions and oncology, announced participation in the Maxim Growth Summit 2026. Senior management will present in a panel discussion focusing on immunology and inflammation therapies. The company highlighted its lead drug candidate ciprocopan recently approv…
GlobalFoundries (Nasdaq: GFS) announced its new FDX Fusion FD-SOI semiconductor platform tailored for Physical AI workloads, targeting manufacturing start in 2028 at its Dresden facility. The 7nm-class technology aims to deliver superior performance, power efficiency, and system integration for automotive, industrial, consumer, and edge AI markets,…
XMax Inc., a NASDAQ-listed distributor of furniture and AI software provider, announced the acquisition of Hexa Creation Inc., a U.S.-based developer of 1200V vertical GaN power semiconductor technology. This strategic move aims to expand XMax's AI ecosystem into high-voltage power infrastructure targeting AI data centers and other applications lik…
Stride, Inc., a leading education technology company, announced the appointment of Dr. Steven Guttentag and Dylan Haggart to its Board of Directors. Alongside these appointments, Stride is forming a Capital Allocation Committee to evaluate its capital structure and priorities, aiming to maximize long-term shareholder value. The company plans to eng…
Quince Therapeutics has rebranded as IRulya Therapeutics following a merger with Orphai Therapeutics and a significant capital raise. The company will trade on Nasdaq under the ticker IRLA, focusing on the clinical development of LAM-001, a novel inhaled formulation of rapamycin targeting mTOR pathways implicated in several severe pulmonary disease…
Filana Therapeutics, a biotechnology firm focused on developing therapies for TSC-related epilepsy, announced its management team's participation in the 2026 Maxim Growth Summit in New York from October 12-14, 2026, where they will engage in one-on-one investor meetings.
VCI Global Limited announced clarification on its US$125 million standby equity purchase facility with Hudson Global Ventures, highlighting that no funds have been drawn to date. The flexible facility allows VCI to access capital over 36 months, aligning with its growth strategies in AI infrastructure and renewable energy projects. The company emph…
Profound Medical Corp. and Telix Pharmaceuticals have entered a co-education agreement to educate healthcare professionals on the complementary roles of Telix's PSMA-PET molecular imaging technologies and Profound's MRI-guided TULSA-PRO platform for prostate cancer care. The collaboration aims to increase physician awareness, facilitate better pati…
Eli Lilly's cardiometabolic franchise continues to dominate industry headlines and company sales. The stock has pulled back from highs but fundamentals and technicals suggest the recent dip is a buying opportunity for a measured 180-day trade. Trade plan, rationale, catalysts, and balanced risks provided.
After a transformational asset sale earlier this year the market is effectively pricing Vistance's remaining networking and access businesses at roughly 2.5x EV/EBITDA and under 0.6x sales. With zero reported debt, a strong current ratio and recent special distributions, VISN looks like a tactical long around current levels. This trade idea lays ou…
Aura Minerals Inc. announced preliminary Q3 2026 production results achieving a record 95,557 gold equivalent ounces (GEO), representing a 27% increase over Q2 2026 and 29% above Q3 2025. Nine-month 2026 production also reached a historic high of over 253,000 GEO, driven by higher grades and throughput primarily at Borborema, Aranzazu, and MSG mine…
VenHub Global, Inc. announced the continued expansion of its intellectual property program focused on autonomous retail Smart Store technology. The company's patent portfolio and planned filings encompass innovations in modular store infrastructure, robotics, AI-driven operations, inventory management, and security systems designed to enhance unatt…
Watsco, Inc., the largest distributor in the North American HVAC market, announced it will release its Q3 2026 earnings before market open on October 27, 2026, followed by a conference call with management. The company highlights its history of growth through organic development and acquisitions, its strong balance sheet, and ongoing investment in …
I am upgrading Pfizer (PFE) from bearish to a cautious bullish stance. The stock offers a mix of reliable free cash flow ($10.99B), a rich dividend yield (~6.14%), and accelerating oncology revenues that should support multiple expansion. This is a trade idea for investors willing to accept company- and sector-specific regulatory risk in exchange f…
The Elmet Group is uniquely positioned as a U.S.-centric tungsten and precision components supplier with direct Department of Defense backing, a freshly solidified supply line via Masan, and a tight float that can amplify upside. We initiate a position with clear entry, stop and target levels and a plan that spans from tactical to position-sized ho…
